Newsletter May 2019 No. 191
Top News
The 31st Pharmaceutical Manufacturers Association of Japan (PMAJ) Policy Seminar held.
On March 11, 2019, the Pharmaceutical Manufacturers Association of Japan (PMAJ) held the 31st PMAJ Policy Seminar at Nihonbashi Mitsui Hall (Chuo-ku, Tokyo) under the theme of "What can we do with pharmaceutical innovation: Contributions and expectations of new drugs and future challenges. In Japan, the declining birthrate, aging population, and shrinking population are rapidly changing the structure of diseases, while the "100-year life period" has been proposed, and new wisdom is required to maintain the social security system. The goal is to create an "angel cycle" in which new drug innovation is the starting point for extending healthy life expectancy, increasing the working population and reducing social security costs and burdens, and the financial resources generated as a result of improved tax revenues are invested in new drug innovation. Representatives from each stakeholder group discussed what roles industry, academia, and government should play to achieve this goal.
Topics
- The Pharmaceutical Industry Policy Institute "20th Anniversary Workshop" Held
- 2019 Life Science Intellectual Property Forum" Held, Theme: "New Drug Business and Intellectual Property in China
- Held a briefing session on "Cost-Effectiveness Evaluation
- The Pharmaceutical Manufacturers Association of Japan (PMAJ) held a media forum under the theme "Value Revolution in Healthcare
- Holding of "Pharmaceutical Association of Japan Media Forum" under the theme of "Lifelong Immunization
- Report on the Intellectual Property Committee's mission to Korea
- Held the 2nd Meeting of Code Compliance Managers
- The 10th Workshop on Environmental Technology held
Policy Research Institute page
From JPMA
Toward the Pursuit of Innovation and the Resolution of Social Issues